SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Essential Therapeutics (ETRX) formerly Microcide (MCDE
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BulbaMan who wrote (154)9/3/1998 1:22:00 AM
From: John O'Neill  Read Replies (1) of 415
 
I've jumped back in at $ 4 1/4. Finding a fungal partner would be news to help. The outcome of the Cephlasporin with J&J would be great if positive. The main challenge is to have an acceptable toxicity level. If J&J OK's project to continue, there will be milestone payment..very good news.

JO
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News